
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7678061
[patent_doc_number] => 20040151765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Methods and compositions for wound management'
[patent_app_type] => new
[patent_app_number] => 10/739841
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9540
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20040151765.pdf
[firstpage_image] =>[orig_patent_app_number] => 10739841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/739841 | Methods and compositions for wound management | Dec 17, 2003 | Abandoned |
Array
(
[id] => 7126951
[patent_doc_number] => 20050058695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Norethindrone sustained release formulations and methods associated therewith'
[patent_app_type] => utility
[patent_app_number] => 10/740373
[patent_app_country] => US
[patent_app_date] => 2003-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8940
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058695.pdf
[firstpage_image] =>[orig_patent_app_number] => 10740373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740373 | Norethindrone sustained release formulations and methods associated therewith | Dec 16, 2003 | Abandoned |
Array
(
[id] => 7097297
[patent_doc_number] => 20050129755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Ingestible capsules containing ethanol'
[patent_app_type] => utility
[patent_app_number] => 10/738243
[patent_app_country] => US
[patent_app_date] => 2003-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2539
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129755.pdf
[firstpage_image] =>[orig_patent_app_number] => 10738243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/738243 | Ingestible capsules containing ethanol | Dec 15, 2003 | Abandoned |
Array
(
[id] => 7675689
[patent_doc_number] => 20040126429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Novel formulation'
[patent_app_type] => new
[patent_app_number] => 10/733508
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9517
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126429.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733508 | Novel formulation | Dec 9, 2003 | Abandoned |
Array
(
[id] => 7468334
[patent_doc_number] => 20040121013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Novel formulation'
[patent_app_type] => new
[patent_app_number] => 10/733665
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9107
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733665 | Novel formulation | Dec 9, 2003 | Abandoned |
Array
(
[id] => 5631063
[patent_doc_number] => 20060147532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Microparticles prepared using an ionic liquid'
[patent_app_type] => utility
[patent_app_number] => 10/537038
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5365
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537038
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537038 | Microparticles prepared using an ionic liquid | Dec 4, 2003 | Abandoned |
Array
(
[id] => 7069114
[patent_doc_number] => 20050244497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Delayed delivery system for acid-sensitive drugs'
[patent_app_type] => utility
[patent_app_number] => 10/478761
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3997
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478761 | Delayed delivery system for acid-sensitive drugs | Nov 23, 2003 | Abandoned |
Array
(
[id] => 7383361
[patent_doc_number] => 20040180005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Method for the production of nanodispersions'
[patent_app_type] => new
[patent_app_number] => 10/478601
[patent_app_country] => US
[patent_app_date] => 2003-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6631
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478601
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478601 | Method for the production of nanodispersions | Nov 18, 2003 | Abandoned |
Array
(
[id] => 7362148
[patent_doc_number] => 20040091531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Novel composition and use'
[patent_app_type] => new
[patent_app_number] => 10/702268
[patent_app_country] => US
[patent_app_date] => 2003-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3670
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10702268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/702268 | Novel composition and use | Nov 4, 2003 | Abandoned |
Array
(
[id] => 10505191
[patent_doc_number] => 09233049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'Pharmaceutical identification'
[patent_app_type] => utility
[patent_app_number] => 10/698981
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10708
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10698981
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/698981 | Pharmaceutical identification | Oct 30, 2003 | Issued |
Array
(
[id] => 7307650
[patent_doc_number] => 20040142040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Formulation and dosage form providing increased bioavailability of hydrophobic drugs'
[patent_app_type] => new
[patent_app_number] => 10/698894
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13733
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10698894
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/698894 | Formulation and dosage form providing increased bioavailability of hydrophobic drugs | Oct 30, 2003 | Abandoned |
Array
(
[id] => 6917738
[patent_doc_number] => 20050095299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Controlled release analgesic suspensions'
[patent_app_type] => utility
[patent_app_number] => 10/697546
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7986
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10697546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/697546 | Controlled release analgesic suspensions | Oct 29, 2003 | Abandoned |
Array
(
[id] => 7286007
[patent_doc_number] => 20040146556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Oral extended release tablets and methods of making and using the same'
[patent_app_type] => new
[patent_app_number] => 10/696044
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9768
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696044
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696044 | Oral extended release tablets and methods of making and using the same | Oct 28, 2003 | Abandoned |
Array
(
[id] => 111109
[patent_doc_number] => 07718188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Transdermal patch for external use comprising fentanyl'
[patent_app_type] => utility
[patent_app_number] => 10/531433
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4330
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531433 | Transdermal patch for external use comprising fentanyl | Oct 16, 2003 | Issued |
Array
(
[id] => 7294811
[patent_doc_number] => 20040213744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Topical spray compositions'
[patent_app_type] => new
[patent_app_number] => 10/686517
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4685
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20040213744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10686517
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/686517 | Topical spray compositions | Oct 15, 2003 | Abandoned |
Array
(
[id] => 32637
[patent_doc_number] => 07785626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Gastric acid secretion inhibiting composition'
[patent_app_type] => utility
[patent_app_number] => 10/531598
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 10771
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785626.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531598 | Gastric acid secretion inhibiting composition | Oct 14, 2003 | Issued |
Array
(
[id] => 5747515
[patent_doc_number] => 20060110446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Deferacirox dispersible tablets'
[patent_app_type] => utility
[patent_app_number] => 10/530856
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5244
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110446.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530856 | Deferacirox dispersible tablets | Oct 13, 2003 | Abandoned |
Array
(
[id] => 7027002
[patent_doc_number] => 20050020658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Selective cyclooxygenase-2 inhibitor patch'
[patent_app_type] => utility
[patent_app_number] => 10/683623
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14555
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020658.pdf
[firstpage_image] =>[orig_patent_app_number] => 10683623
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/683623 | Selective cyclooxygenase-2 inhibitor patch | Oct 9, 2003 | Abandoned |
Array
(
[id] => 7230830
[patent_doc_number] => 20040156900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Time pulsed release composition'
[patent_app_type] => new
[patent_app_number] => 10/474360
[patent_app_country] => US
[patent_app_date] => 2003-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6578
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156900.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474360
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474360 | Time pulsed release composition | Oct 8, 2003 | Abandoned |
Array
(
[id] => 5873164
[patent_doc_number] => 20060165794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Spheroids, preparation method thereof and pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/530052
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5396
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165794.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530052 | Spheroids, preparation method thereof and pharmaceutical compositions | Oct 2, 2003 | Abandoned |